Previous Section
Review Articles
1. Taxane refractory prostate cancer.
- Author
- Mathew P; Dipaola R;
- Institution
- M. D. Anderson Cancer Center, Houston, Texas, USA.
- Journal
- J Urol. 2007 Sep;178(3 Pt 2):S36-41. Epub 2007 Jul 20.
- Abstract URL
- Click here to view abstract
2. Bone directed therapies for prostate cancer.
- Author
- Bradley DA; Hussain M; Dipaola RS; Kantoff P;
- Institution
- Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA.
- Journal
- J Urol. 2007 Sep;178(3 Pt 2):S42-8. Epub 2007 Jul 20.
- Abstract URL
- Click here to view abstract
3. Cryotherapy for localised prostate cancer.
- Author
- Shelley M; Wilt TJ; Coles B; Mason MD;
- Institution
- Velindre NHS Trust, Research Laboratories, Velindre Road, Whitchurch, Cardiff, Wales, UK, CF4 7XL. mike.shelley@velindre-tr.wales.nhs.uk
- Journal
- Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005010.
- Abstract URL
- Click here to view abstract
4. ProstaScint and its role in the diagnosis of prostate cancer.
- Author
- Mohammed AA; Shergill IS; Vandal MT; Gujral SS;
- Institution
- King George Hospital, Department of Urology, Essex, UK. aza_bamerny@yahoo.com
- Journal
- Expert Rev Mol Diagn. 2007 Jul;7(4):345-9.
- Abstract URL
- Click here to view abstract
5. High-intensity focused ultrasound (HIFU) for prostate cancer.
- Author
- Murat FJ; Poissonnier L; Pasticier G; Gelet A;
- Institution
- Urology and Transplantation Department, Edouard Herriot Hospital, 69347 Lyon Cedex 03, France. gfj-murat@club-internet.fr
- Journal
- Cancer Control. 2007 Jul;14(3):244-9.
- Abstract URL
- Click here to view abstract
6. Counterpoint: prostate cancer life expectancy can not be accurately predicted from currently available tools.
- Author
- McCloskey SA; Kuettel MR;
- Institution
- Department of Radiation Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.
- Journal
- J Natl Compr Canc Netw. 2007 Aug;5(7):709-13.
- Abstract URL
- Click here to view abstract
7. Point: the value of predicting life expectancy in men with clinically localized prostate cancer.
- Author
- Clayton DB; Urban DA;
- Institution
- Department of Surgery, Division of Urology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.
- Journal
- J Natl Compr Canc Netw. 2007 Aug;5(7):703-8.
- Abstract URL
- Click here to view abstract
8. Point: active surveillance for favorable risk prostate cancer.
- Author
- Klotz L;
- Institution
- University of Toronto, Division of Urology, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue #MG408, Toronto, Ontario, Canada. Laurence.klotz@sunnybrook.ca
- Journal
- J Natl Compr Canc Netw. 2007 Aug;5(7):693-8.
- Abstract URL
- Click here to view abstract
9. Quality of life for men with prostate cancer.
- Author
- Katz A;
- Institution
- CancerCare Manitoba, Winnipeg, Manitoba, Canada. anne.katz@cancercare.mb.ca
- Journal
- Cancer Nurs. 2007 Jul-Aug;30(4):302-8.
- Abstract URL
- Click here to view abstract
10. Review of primary and salvage cryoablation for prostate cancer.
- Author
- Chin JL; Lim D; Abdelhady M;
- Institution
- Division of Urological Surgery, University of Western Ontario, London, Canada N6A 4G5. joseph.chin@lhsc.on.ca
- Journal
- Cancer Control. 2007 Jul;14(3):231-7.
- Abstract URL
- Click here to view abstract
